Cuu Long Pharmaceutical Joint Stock Company Sustainability Profile
Cuu Long Pharmaceutical Joint Stock Company, commonly referred to as Cuu Long Pharma, is a prominent player in the pharmaceutical industry, headquartered in Vietnam. Established in 2001, the company has made significant strides in the production and distribution of high-quality pharmaceutical products across various regions in Vietnam. Cuu Long Pharma focuses on the development of generic medicines, herbal products, and dietary supplements, setting itself apart with a commitment to innovation and quality. The company has achieved notable milestones, including certifications from international quality standards, which bolster its reputation in the market. With a strong market position, Cuu Long Pharmaceutical is recognised for its extensive product range and dedication to improving healthcare outcomes. Its unique offerings and strategic operational approach have solidified its status as a trusted name in the Vietnamese pharmaceutical landscape.
DitchCarbon Score
How does Cuu Long Pharmaceutical Joint Stock Company's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Cuu Long Pharmaceutical Joint Stock Company's score of 20 is lower than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Cuu Long Pharmaceutical Joint Stock Company's reported carbon emissions
Cuu Long Pharmaceutical Joint Stock Company, headquartered in Vietnam, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Cuu Long Pharmaceutical may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. In the context of the pharmaceutical industry, companies are increasingly recognising the importance of sustainability and climate action. However, without specific emissions data or reduction initiatives, it is challenging to assess Cuu Long Pharmaceutical's position relative to industry standards. As the company moves forward, establishing measurable climate commitments and reporting emissions could enhance its sustainability profile and align it with global climate goals.
How Carbon Intensive is Cuu Long Pharmaceutical Joint Stock Company's Industry?
How Carbon Intensive is Cuu Long Pharmaceutical Joint Stock Company's Location?
Cuu Long Pharmaceutical Joint Stock Company's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Cuu Long Pharmaceutical Joint Stock Company has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
